Original Research
Accepted on 21 Feb 2025
Fruquintinib inhibits the migration and invasion of colorectal cancer cells by modulating epithelial-mesenchymal transition via TGF-β/Smad signaling pathway
in Gastrointestinal Cancers: Gastric and Esophageal Cancers